摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

acetic acid-(1-isopropyl-pentyl ester) | 116496-84-5

中文名称
——
中文别名
——
英文名称
acetic acid-(1-isopropyl-pentyl ester)
英文别名
Essigsaeure-(1-isopropyl-pentylester);Acetic acid 1-isopropyl-pentyl ester;2-methylheptan-3-yl acetate
acetic acid-(1-isopropyl-pentyl ester)化学式
CAS
116496-84-5
化学式
C10H20O2
mdl
MFCD00049103
分子量
172.268
InChiKey
MOAHBTJSRYNEIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • IMPROVED MEDICAL DEVICE HAVING DESIRABLE COMBINATION OF PROPERTIES AND METHOD OF MAKING SAME
    申请人:Medtronic AVE, Inc.
    公开号:EP0983097A1
    公开(公告)日:2000-03-08
  • [EN] IMPROVED MEDICAL DEVICE HAVING DESIRABLE COMBINATION OF PROPERTIES AND METHOD OF MAKING SAME<br/>[FR] DISPOSITIF MEDICAL AMELIORE PRESENTANT UNE COMBINAISON DE PROPRIETES VOULUES, ET SON PROCEDE DE FABRICATION
    申请人:MEDTRONIC AVE,INC.
    公开号:WO1998050087A1
    公开(公告)日:1998-11-12
    (EN) This invention relates to coated medical devices adapted to pass through narrow body openings such as catheters. The coatings provided by this invention impart durability to the catheter without appreciably adding to the thickness of the catheter and without decreasing the hoop tensile strength of the catheter.(FR) L'invention a trait à des dispositifs médicaux revêtus, conçus pour passer à travers des ouvertures de corps étroits, tels que des cathéters. Les revêtements prévus par l'invention confèrent une durabilité au cathéter sans accroître de façon appréciable l'épaisseur du cathéter, et sans réduire la résistance à la traction périphérique du cathéter.
  • [EN] METHOD OF PRODUCING ACETOXYARYL CARBOXYLIC ACIDS<br/>[FR] PROCEDE DE PRODUCTION D'ACIDES CARBOXYLIQUES D'ACETOXYARYLE
    申请人:EASTMAN CHEM CO
    公开号:WO2000027787A1
    公开(公告)日:2000-05-18
    A method of producing an acetoxyaryl carboxylic acid converts a dialkylaryl to a monohydroperoxide of the dialkylaryl, converts the monohydroperoxide of the dialkylaryl to an alkylaryl acetate, and oxidizes the alkylaryl acetate to the acetoxyaryl carboxylic acid in the presence of cobalt and bromine catalysts. If the alkyl groups are isopropyl groups, the method converts a monohydroperoxide of a diisopropylaryl to an isopropylaryl acetate and oxidizes the isopropylaryl acetate to the acetoxyaryl carboxylic acid in the presence of cobalt and bromine catalysts. Alternatively, it is possible to produce the acetoxyaryl carboxylic acid from an isopropylaryl alcohol. In this case, the isopropylaryl alcohol is converted to an isopropylaryl acetate and the isopropylaryl acetate is oxidized to the acetoxyaryl carboxylic acid in the presence of cobalt and bromine catalysts. The isopropylaryl acetate may be isolated prior to the oxidation step. Alternatively, the isopropylaryl acetate may not be isolated prior to the oxidation substep. However, acetone is produced in the step of converting the monohydroperoxide of the diisopropylaryl to the isopropylaryl acetate, and the acetone should be removed prior to the oxidation step. The aryl group may be a phenyl group or a naphthyl group. The oxidation step may be conducted in the presence of cobalt, bromine and manganese catalysts and more preferably in the presence of cobalt, bromine, manganese and potassium catalysts. The cobalt concentration should be within the range of from 0.01 molar to 0.05 molar and more preferably within the range of from 0.02 molar to 0.03 molar.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸